Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Reporting to the Senior Director, Talent Acquisition, this individual will serve as a strategic, hands-on partner to Commercial leadership, supporting launch readiness through thoughtful workforce planning, strong talent pipelines, and disciplined recruiting execution.